Hints and tips:
Related Special Reports
...The US Food and Drug Administration in late 2021 gave a severely restricted emergency approval, making it a treatment available to those for whom other drugs were not recommended....
...In the US, the Food and Drug Administration in late 2021 approved emergency use for certain categories of patients....
...bioethics at the University of Washington School of Medicine in Seattle, said that while Pfizer’s plan was welcome news, it should not be left to for-profit companies to set policy during global health emergencies...
...pilot of Palantir’s Foundry system at the Chelsea and Westminster Hospital Trust helped reduce the inpatient waiting list by 28 per cent — the equivalent of tens of thousands of patients — for all non-emergency...
...Envision Healthcare, a KKR-owned company that employs doctors who staff emergency rooms and anaesthesiology departments in hundreds of US hospitals, sued UnitedHealthcare in 2018 in a dispute over billing...
...However, Paxlovid will be covered by medical insurance until March 31 under the terms of an emergency deal....
...Blackstone acquired hospital staffing supplier Team Health in 2016 and two years later, KKR bought physician services and emergency room operator Envision Healthcare for $9.9bn....
...Under the terms of an emergency agreement, Paxlovid qualifies for reimbursement through the end of March....
...In just six US states that collected the data in 2020, more than 10,000 were on Medicaid, the medical insurance system for those on low incomes....
...Pfizer and BioNTech have applied to US regulatory authorities for emergency authorisation of a Covid-19 vaccine specifically tailored to target the most dominant strain of the Omicron coronavirus variant...
...Destiny also played a part when, in 1949, Harvard asked him to pay a $10,000 bribe to dodge an anti-Semitic quota for Jewish medical students....
...Pfizer has said it will seek emergency authorisation in the US for its Covid-19 vaccine for children under the age of five after interim results from its clinical trial showed the jab is safe and highly...
...One potential solution would be to allow the Premier League to distribute tickets for away fans coming to Stamford Bridge....
...The decision will delay the emergency use authorisation of a jab for children aged six months to 4 years of age for a few months, even though there are still a “staggering number” of new Covid-19 cases reported...
...UK and EU regulators granted emergency use or conditional authorisation for the treatment last month....
...The Food and Drug Administration announced on Monday it was removing its emergency authorisation for doctors to prescribe the treatments, which work by infusing patients with proteins that mimic the body...
...Regulators in the UK and EU, where countries are battling a fresh wave of infections ahead of winter, granted emergency use authorisation for molnupiravir this month....
...The European Medicines Agency could approve the Novavax two-dose coronavirus vaccine as early as next week, paving the way for emergency use listing from the World Health Organization, according to people...
...The European Medicines Agency has begun a full review of the drug after giving it an emergency nod — not an approval — that allows member states to go ahead with its use on a national basis....
...The US drugs regulator on Wednesday gave emergency authorisation for the pill, called Paxlovid, to be used on people aged 12 and over with mild or moderate Covid-19 who are at risk of more severe symptoms...
...The US Food and Drug Administration is reviewing clinical trial data and is expected to issue an emergency authorisation for the drug soon. The US has ordered 10m courses of the antiviral....
...It is seeking to do so as an immediate emergency rule rather than through a formal rulemaking process, which could take months....
...“For a place with that volume and acuity [medical urgency], it is just not safe not to have multiple attendings supervising the residents and physician assistants.”...
...Advisers to the US Food and Drug Administration are due to consider whether to grant an emergency use authorisation for molnupiravir at a meeting later this month....
...It is one of the first royalty-free licensing agreements struck by a pharmaceutical company for a key Covid-19 medical technology and should boost generic manufacturing of Merck’s drug molnupiravir if it...
International Edition